BP

Badri Prasad Ganeshrao Rathod

Active Director Director DIN 11585256
DIN 11585256 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Badri Prasad Ganeshrao Rathod

Data last updated:

Badri Prasad Ganeshrao Rathod is a Director at Cytonix Pharma Private Limited (since 2026).

DIN 11585256
Primary Designation Director
First Appointment 05 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytonix Pharma Private Limited U46497ME2026PTC473670
Director05 Mar 20262026Active

Board colleagues of Badri Prasad Ganeshrao Rathod

NameDINCompanyDesignation
Rahul Deepak Rathi11585255Cytonix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cytonix Pharma Private Limited
Premium access

Shareholding and investment profile for Badri Prasad Ganeshrao Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Badri Prasad Ganeshrao Rathod

Badri Prasad Ganeshrao Rathod currently holds 1 directorship: Cytonix Pharma Private Limited (Director, since 05 Mar 2026).

Badri Prasad Ganeshrao Rathod was first appointed on 05 Mar 2026 as Director at Cytonix Pharma Private Limited.

The current boards of Badri Prasad Ganeshrao Rathod's companies include Rahul Deepak Rathi (Cytonix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available